Experic Battle Card: CCO Jeffrey Shane Trigger

🚀 Battle Card: Experic

• Jeffrey Shane, Chief Commercial Officer · 🔗 LinkedIn

• Bringing in a Harro Höfliger veteran with board tenure supercharges their CDMO go-to-market and clinical trial supply expansion → Source

• Speed to clinic for complex formulations

• Scalability & reliability in inhalation/powder supply

• Primary: Contract Development & Manufacturing Services → Accelerated drug development and robust clinical supply

• Expansion: Inhalation & Challenging Powders Expertise → Differentiated delivery with built-in regulatory compliance

• HQ: Cranbury, NJ

• Employees: ≈ 150

• Rev: ≈ $50 M

• Website: expericservices.com

🤼 Competitive Intel

• Catalent — CDMO / Clinical Supply
• Unique edge: End-to-end global network
• Evaluated by CCO for scalability on inhalation projects

• Lonza — CDMO / Biologics & Small Molecules
• Unique edge: Deep regulatory expertise
• Evaluated by VP Ops for high-volume manufacturing

• Thermo Fisher Scientific — CDMO / Clinical Trial Logistics
• Unique edge: Integrated cold-chain solutions
• Evaluated by Dir. Supply Chain for global distribution

• Recipharm — CDMO / Drug Product Services
• Unique edge: Modular service offerings
• Evaluated by VP Quality for flexibility in formulation

• PCI Pharma Services — CDMO / Clinical Packaging & Distribution
• Unique edge: End-to-end supply chain visibility
• Evaluated by Dir. Clinical Ops for tight timelines

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑NewsletterForLeads❑
OFFER_BRIEF   = ❑rapid clinical supply solution❑
PROOF_METRIC  = ❑reduced delays by 30%❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Jeffrey
COMPANY     = Experic
DEPT        = Commercial
SIZE        = ≈ TBD
BOTTLENECK  = speed to clinic for complex formulations
EVENT       = Appointment of Jeffrey Shane as Chief Commercial Officer
DETAIL      = Appointment of Jeffrey Shane as Chief Commercial Officer
PAIN        = scalability & reliability in inhalation/powder supply
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250903886978&div=41152219
SIM_CO      = Catalent
WIN_METRIC  = 25% faster time-to-clinic
NEXT_SIZE   = ≈ TBD
EMP_EST     = ≈ 150
REV_EST     = ≈ $50M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈ TBD-person Commercial

Jeffrey—noticed your Commercial team is ≈ TBD.

That’s when speed to clinic for complex formulations slows growth.

We helped Catalent fix this with rapid clinical supply solution.

Result: 25% faster time-to-clinic.
Quick call?

PS—next bottleneck hits ≈ TBD.

DM ≤45 words, TONE:
Saw your post about Appointment of Jeffrey Shane as Chief Commercial Officer — scalability & reliability in inhalation/powder supply.
rapid clinical supply solution. reduced delays by 30%.
Quick chat?